Ortin Global P/B Ratio
Ortin Global P/B ratio. Ortin Global (ORTINGLOBE) P/B ratio is 9.47 (High), book value per share ₹1.25 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse Ortin Global ownership pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ORTINGLOBE P/B Ratio — Valuation Insights & Book Value Analysis
Ortin Global price-to-book ratio interpretation, valuation status and historical context — current P/B 9.47 (High). View Ortin Global yearly highs lows for the annual high/low range and current price position.
- Stock appears overvalued with PB of 9.47, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 86.6% above historical average
- Trading at premium to sector average PB of 0.01
Ortin Global P/B Ratio Historical Trend
ORTINGLOBE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Ortin Global share price screener.
ORTINGLOBE Historical P/B Ratio — Book Value Per Share & Year-End Price
Ortin Global annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 11.06 | ₹1.25 | ₹13.82 | ₹1 | High |
| 2025 | 6.16 | ₹2.5 | ₹15.41 | ₹2 | High |
| 2024 | 4.77 | ₹3.75 | ₹17.90 | ₹3 | High |
| 2023 | 1.67 | ₹13.75 | ₹23.02 | ₹11 | Moderate |
| 2022 | 1.72 | ₹13.75 | ₹23.70 | ₹11 | Moderate |
ORTINGLOBE vs Healthcare Peers — P/B Ratio Comparison
Ortin Global P/B 9.47 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |